Chenguang Biotech Group (300138.SZ) plans to repurchase company shares worth 80 to 160 million yuan.

22:21 02/07/2026

In the announcement released by Sunshine Biopharma (300138.SZ), the company plans to use its own funds to repurchase a portion of its RMB ordinary shares in A shares through centralized bidding trading, and to cancel them in order to reduce the company's registered capital. The total amount of repurchase funds shall not be less than RMB 80 million (inclusive) and shall not exceed RMB 160 million (inclusive), with the repurchase price not exceeding RMB 12.50 per share (inclusive).

Chenguang Biotech Group (300138.SZ) announced that the company plans to use its own funds to repurchase some RMB ordinary A shares through centralized competitive trading, in order to cancel and reduce the company's registered capital. The total amount of repurchase funds shall not be less than RMB 80 million (inclusive) and not more than RMB 160 million (inclusive), with the repurchase price not exceeding RMB 12.50 per share (inclusive).

KUAISHOU-W (01024): Initial investors intend to increase their investment in Beijing Kaleido by $2.028 billion.

A-share evening hot spots | Unisoc Technology's IPO registration approved A-share "Siasun Robot&Automation first stock" is coming?

Keling AI has successfully raised nearly $3 billion in funding, setting a new record for the financing size of video AI companies worldwide.

KUAISHOU-W (01024): Initial investors intend to increase their investment in Beijing Kaleido by $2.028 billion.

A-share evening hot spots | Unisoc Technology's IPO registration approved A-share "Siasun Robot&Automation first stock" is coming?

Keling AI has successfully raised nearly $3 billion in funding, setting a new record for the financing size of video AI companies worldwide.